Related Experiment Video
Updated: Jun 5, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification
1Department of Nephrology, Shanghai Tianyou Hospital, School of Medicine, Tongji University, Shanghai, China.
Insights
The bone-vascular axis significantly impacts vascular calcification in chronic kidney disease (CKD). Managing bone metabolism markers is crucial for treating CKD-mineral and bone disorder (CKD-MBD) complications.
Area of Science:
- Endocrinology
- Nephrology
- Vascular Biology
Background:
- The bone-vascular axis is integral to vascular calcification (VC) pathogenesis in chronic kidney disease (CKD).
- CKD-mineral and bone disorder (CKD-MBD) management is vital for preventing osteoporosis, arterial calcification, and cardiovascular diseases.
- Uremic toxins drive VC by inducing vascular smooth muscle cell transdifferentiation.
Purpose of the Study:
- To comprehensively review the role of bone metabolism markers in uremic VC.
- To elucidate the mechanisms linking bone and vascular health in CKD.
- To highlight therapeutic targets for CKD-MBD.
Main Methods:
- Literature review of studies on the bone-vascular axis in CKD.
- Analysis of the role of specific bone metabolism markers.
- Synthesis of current understanding of VC pathogenesis in CKD.
Main Results:
- The skeleton acts as an endocrine organ, influencing systemic metabolism and vascular remodeling.
- Sclerostin, from bone cells, can protect against WNT-induced calcification.
- Therapeutic strategies aim to reduce sclerostin production and osteogenic smooth muscle cell differentiation.
- Calciprotein particles facilitate calcium-phosphate delivery and FGF-23 expression.
Conclusions:
- Bone metabolism markers are critical targets for managing VC in CKD.
- Understanding the bone-vascular axis offers new therapeutic avenues for CKD-MBD.
- Interventions targeting sclerostin and vascular smooth muscle cell differentiation show promise.
Background:
The bone-vascular axis plays a key role in the pathogenesis of vascular calcification (VC) in patients with chronic kidney disease (CKD). Understanding and managing the role of the bone-vascular axis in CKD-mineral and bone disorder (CKD-MBD) is critical for preventing and treating associated complications, including osteoporosis, arterial calcification, and cardiovascular diseases. This study aimed to comprehensively summarize the role of bone metabolism markers in uremic VC.
Summary:
The skeleton, as an endocrine organ, can regulate systemic metabolic processes by secreting various bioactive substances. These molecules can induce the transdifferentiation of vascular smooth muscle cells, promoting their transition to other functional states, thereby affecting vascular growth and remodeling.
Key Messages:
The prevalence of VC in individuals with CKD is notably high. CKD-associated VC is characterized by the widespread accumulation of hydroxyapatite within the arterial media, which occurs as a result of the transformation of smooth muscle cells into osteoblastic smooth muscle cells under the influence of uremic toxins. Osteoblasts and osteoclasts in bone tissue secrete mineral metabolic proteins, which can influence neighboring cells, primarily vascular smooth muscle cells, through paracrine signaling. Both circulating and osteocytic sclerostin can exert a protective effect by inhibiting wingless/integrated (WNT)-induced calcification. The therapeutic goal for CKD-MBD is to reduce production of sclerostin by decreasing the osteogenic transdifferentiation of vascular smooth muscle cells. Calciprotein particles act as a physiological agent for delivering calcium-phosphate the bone and inducing fibroblast growth factor-23 expression in osteoblasts.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Skeleton and Calcium Homeostasis
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
The Bone Matrix

